Good morning, folks. How are you today? Once again, sunny skies and a cool breeze are enveloping the Pharmalot campus, which is a rather quiet place right now, other than the familiar whistle of the coffee kettle on the stove. Our short person is quietly snoozing and the official mascot is napping. We would join them but, alas, there is much to be done. Most likely, you know the feeling. So here are some tidbits to get you started. Hope all goes well today and you conquer the world. …
The European Commission said on Thursday it had reached a temporary agreement with South Africa to use a plant there to bottle Johnson & Johnson (JNJ) Covid-19 vaccines that are being imported into the European Union, Reuters reports. On Wednesday, the World Health Organization Director-General Tedros Adhanom Ghebreyesus said he was “stunned” by news J&J vaccines were being exported from South Africa to the EU, because the EU has very high vaccination rates but in many African countries, not even the most vulnerable are vaccinated.
The WHO and Unitaid called on Roche (RHHBY) to ensure that existing doses of its Actemra medicine, which is being used to treat Covid-19 patients, are equally available to low- and middle-income countries in the face of a global shortage, STAT writes. The global health agencies want the company to transfer technology and share know-how and data to increase the number of qualified manufacturers. U.S. demand is spiking well beyond 400% of what was seen prior to the pandemic.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
